BIODESIX INC 8-K/A

What Happened
Biodesix, Inc. (BDSX) announced on January 12, 2026 that it issued a press release containing certain preliminary and unaudited financial results for the fourth quarter and the year ended December 31, 2025. The company filed an 8‑K to report this release and incorporated the press release as Exhibit 99.1 to the report. The filing was signed by Chief Financial Officer Robin Harper Cowie.

Key Details

• Date filed: January 12, 2026.
• Reporting period: fourth quarter and full year ended December 31, 2025.
• Nature of results: described as preliminary and unaudited (subject to change upon completion of audits).
• Press release included as Exhibit 99.1 and the interactive XBRL cover page file (104) was provided.

Why It Matters
Preliminary, unaudited results give investors an early view of Biodesix’s earnings and revenue trends for Q4 and 2025 before final audited statements and periodic reports are filed. Because the results are unaudited and preliminary, they can change during final close and audit processes; investors should watch for the company’s subsequent earnings release, 10‑K or 8‑K with final audited figures and any related commentary from management.